nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—HTR6—Alzheimer's disease	0.204	0.514	CbGaD
Imipramine—SLC6A4—Alzheimer's disease	0.0779	0.197	CbGaD
Imipramine—SLC22A2—Memantine—Alzheimer's disease	0.0692	0.209	CbGbCtD
Imipramine—HTR2A—Donepezil—Alzheimer's disease	0.0602	0.182	CbGbCtD
Imipramine—HTR2A—Alzheimer's disease	0.0599	0.151	CbGaD
Imipramine—CYP2D6—Alzheimer's disease	0.0548	0.138	CbGaD
Imipramine—DRD2—Memantine—Alzheimer's disease	0.0481	0.145	CbGbCtD
Imipramine—CYP2B6—Memantine—Alzheimer's disease	0.0359	0.108	CbGbCtD
Imipramine—CYP2D6—Rivastigmine—Alzheimer's disease	0.025	0.0756	CbGbCtD
Imipramine—CYP2C19—Memantine—Alzheimer's disease	0.0228	0.0689	CbGbCtD
Imipramine—CYP2D6—Donepezil—Alzheimer's disease	0.02	0.0604	CbGbCtD
Imipramine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0159	0.0481	CbGbCtD
Imipramine—CYP2D6—Galantamine—Alzheimer's disease	0.0129	0.039	CbGbCtD
Imipramine—CYP3A4—Donepezil—Alzheimer's disease	0.0127	0.0384	CbGbCtD
Imipramine—CYP3A4—Galantamine—Alzheimer's disease	0.0082	0.0248	CbGbCtD
Imipramine—HTR2C—choroid plexus—Alzheimer's disease	0.00536	0.0845	CbGeAlD
Imipramine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00276	0.0436	CbGeAlD
Imipramine—HTR2A—choroid plexus—Alzheimer's disease	0.00269	0.0424	CbGeAlD
Imipramine—HTR7—locus ceruleus—Alzheimer's disease	0.00266	0.042	CbGeAlD
Imipramine—HTR2A—locus ceruleus—Alzheimer's disease	0.00166	0.0262	CbGeAlD
Imipramine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00162	0.0256	CbGeAlD
Imipramine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00157	0.0248	CbGeAlD
Imipramine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00135	0.0214	CbGeAlD
Imipramine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00132	0.0208	CbGeAlD
Imipramine—HTR7—telencephalic ventricle—Alzheimer's disease	0.00126	0.0199	CbGeAlD
Imipramine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00119	0.0188	CbGeAlD
Imipramine—KCND2—forebrain—Alzheimer's disease	0.000954	0.0151	CbGeAlD
Imipramine—KCND2—telencephalon—Alzheimer's disease	0.000877	0.0138	CbGeAlD
Imipramine—KCND3—forebrain—Alzheimer's disease	0.000832	0.0131	CbGeAlD
Imipramine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000787	0.0124	CbGeAlD
Imipramine—KCND3—telencephalon—Alzheimer's disease	0.000765	0.0121	CbGeAlD
Imipramine—HTR6—forebrain—Alzheimer's disease	0.000709	0.0112	CbGeAlD
Imipramine—HTR6—telencephalon—Alzheimer's disease	0.000652	0.0103	CbGeAlD
Imipramine—HTR7—blood vessel—Alzheimer's disease	0.000625	0.00986	CbGeAlD
Imipramine—ADRA1D—forebrain—Alzheimer's disease	0.000554	0.00874	CbGeAlD
Imipramine—KCND2—nervous system—Alzheimer's disease	0.000518	0.00817	CbGeAlD
Imipramine—ADRA1D—telencephalon—Alzheimer's disease	0.000509	0.00803	CbGeAlD
Imipramine—KCND2—central nervous system—Alzheimer's disease	0.000499	0.00787	CbGeAlD
Imipramine—KCND2—cerebellum—Alzheimer's disease	0.000487	0.00769	CbGeAlD
Imipramine—Olopatadine—S100B—Alzheimer's disease	0.000474	0.111	CrCbGaD
Imipramine—KCND3—nervous system—Alzheimer's disease	0.000452	0.00713	CbGeAlD
Imipramine—SLC22A3—embryo—Alzheimer's disease	0.000451	0.00712	CbGeAlD
Imipramine—KCND3—central nervous system—Alzheimer's disease	0.000435	0.00686	CbGeAlD
Imipramine—CHRM4—nervous system—Alzheimer's disease	0.00043	0.00679	CbGeAlD
Imipramine—CHRM2—forebrain—Alzheimer's disease	0.000425	0.00671	CbGeAlD
Imipramine—KCND3—cerebellum—Alzheimer's disease	0.000425	0.00671	CbGeAlD
Imipramine—SLC6A3—forebrain—Alzheimer's disease	0.000424	0.00669	CbGeAlD
Imipramine—SLC22A1—forebrain—Alzheimer's disease	0.000418	0.00659	CbGeAlD
Imipramine—CHRM4—central nervous system—Alzheimer's disease	0.000414	0.00654	CbGeAlD
Imipramine—HTR2C—forebrain—Alzheimer's disease	0.00041	0.00647	CbGeAlD
Imipramine—KCND2—brain—Alzheimer's disease	0.000396	0.00625	CbGeAlD
Imipramine—CHRM2—telencephalon—Alzheimer's disease	0.000391	0.00617	CbGeAlD
Imipramine—SLC6A3—telencephalon—Alzheimer's disease	0.00039	0.00615	CbGeAlD
Imipramine—HTR2A—blood vessel—Alzheimer's disease	0.00039	0.00615	CbGeAlD
Imipramine—SLC6A4—forebrain—Alzheimer's disease	0.000388	0.00613	CbGeAlD
Imipramine—CHRM1—forebrain—Alzheimer's disease	0.000387	0.00611	CbGeAlD
Imipramine—HTR6—nervous system—Alzheimer's disease	0.000385	0.00608	CbGeAlD
Imipramine—SLC22A1—telencephalon—Alzheimer's disease	0.000384	0.00606	CbGeAlD
Imipramine—HTR2C—telencephalon—Alzheimer's disease	0.000377	0.00595	CbGeAlD
Imipramine—HTR6—central nervous system—Alzheimer's disease	0.000371	0.00585	CbGeAlD
Imipramine—SLC6A4—telencephalon—Alzheimer's disease	0.000357	0.00564	CbGeAlD
Imipramine—CHRM1—telencephalon—Alzheimer's disease	0.000356	0.00562	CbGeAlD
Imipramine—CHRM3—forebrain—Alzheimer's disease	0.000346	0.00547	CbGeAlD
Imipramine—KCND3—brain—Alzheimer's disease	0.000345	0.00545	CbGeAlD
Imipramine—HTR1A—forebrain—Alzheimer's disease	0.000345	0.00544	CbGeAlD
Imipramine—SLC6A2—forebrain—Alzheimer's disease	0.000342	0.0054	CbGeAlD
Imipramine—CHRM5—nervous system—Alzheimer's disease	0.000336	0.00531	CbGeAlD
Imipramine—HTR7—forebrain—Alzheimer's disease	0.00033	0.0052	CbGeAlD
Imipramine—CHRM4—brain—Alzheimer's disease	0.000329	0.00519	CbGeAlD
Imipramine—CHRM5—central nervous system—Alzheimer's disease	0.000324	0.00511	CbGeAlD
Imipramine—CHRM3—telencephalon—Alzheimer's disease	0.000318	0.00503	CbGeAlD
Imipramine—ADRA1A—forebrain—Alzheimer's disease	0.000318	0.00502	CbGeAlD
Imipramine—HTR1A—telencephalon—Alzheimer's disease	0.000317	0.00501	CbGeAlD
Imipramine—SLC6A2—telencephalon—Alzheimer's disease	0.000314	0.00496	CbGeAlD
Imipramine—DRD2—forebrain—Alzheimer's disease	0.000312	0.00492	CbGeAlD
Imipramine—ADRA1B—nervous system—Alzheimer's disease	0.000307	0.00485	CbGeAlD
Imipramine—KCNH2—forebrain—Alzheimer's disease	0.000307	0.00485	CbGeAlD
Imipramine—Pancytopenia—Memantine—Alzheimer's disease	0.000307	0.00243	CcSEcCtD
Imipramine—HTR7—telencephalon—Alzheimer's disease	0.000303	0.00478	CbGeAlD
Imipramine—Vision blurred—Galantamine—Alzheimer's disease	0.000301	0.00239	CcSEcCtD
Imipramine—ADRA1D—nervous system—Alzheimer's disease	0.000301	0.00474	CbGeAlD
Imipramine—Tremor—Galantamine—Alzheimer's disease	0.000299	0.00237	CcSEcCtD
Imipramine—Pollakiuria—Memantine—Alzheimer's disease	0.000298	0.00236	CcSEcCtD
Imipramine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000297	0.00236	CcSEcCtD
Imipramine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000297	0.00235	CcSEcCtD
Imipramine—ADRA1B—central nervous system—Alzheimer's disease	0.000296	0.00467	CbGeAlD
Imipramine—HTR6—brain—Alzheimer's disease	0.000294	0.00464	CbGeAlD
Imipramine—Weight increased—Memantine—Alzheimer's disease	0.000294	0.00233	CcSEcCtD
Imipramine—Agitation—Galantamine—Alzheimer's disease	0.000294	0.00233	CcSEcCtD
Imipramine—ADRA1A—telencephalon—Alzheimer's disease	0.000292	0.00461	CbGeAlD
Imipramine—Weight decreased—Memantine—Alzheimer's disease	0.000292	0.00231	CcSEcCtD
Imipramine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000292	0.00231	CcSEcCtD
Imipramine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000291	0.0023	CcSEcCtD
Imipramine—ADRA1D—central nervous system—Alzheimer's disease	0.000289	0.00457	CbGeAlD
Imipramine—Malaise—Galantamine—Alzheimer's disease	0.000288	0.00228	CcSEcCtD
Imipramine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000288	0.00228	CcSEcCtD
Imipramine—Infestation NOS—Memantine—Alzheimer's disease	0.000288	0.00228	CcSEcCtD
Imipramine—Infestation—Memantine—Alzheimer's disease	0.000288	0.00228	CcSEcCtD
Imipramine—Weight increased—Rivastigmine—Alzheimer's disease	0.000287	0.00228	CcSEcCtD
Imipramine—Syncope—Galantamine—Alzheimer's disease	0.000287	0.00227	CcSEcCtD
Imipramine—DRD2—telencephalon—Alzheimer's disease	0.000287	0.00452	CbGeAlD
Imipramine—Weight decreased—Rivastigmine—Alzheimer's disease	0.000286	0.00226	CcSEcCtD
Imipramine—Hepatitis—Donepezil—Alzheimer's disease	0.000285	0.00225	CcSEcCtD
Imipramine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000284	0.00225	CcSEcCtD
Imipramine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000283	0.00224	CcSEcCtD
Imipramine—Hallucination—Donepezil—Alzheimer's disease	0.000283	0.00224	CcSEcCtD
Imipramine—Palpitations—Galantamine—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Imipramine—KCNH2—telencephalon—Alzheimer's disease	0.000282	0.00446	CbGeAlD
Imipramine—Myocardial infarction—Memantine—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Imipramine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000282	0.00224	CcSEcCtD
Imipramine—Infestation—Rivastigmine—Alzheimer's disease	0.000282	0.00223	CcSEcCtD
Imipramine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000282	0.00223	CcSEcCtD
Imipramine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000282	0.00223	CcSEcCtD
Imipramine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000281	0.00223	CcSEcCtD
Imipramine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000281	0.00223	CcSEcCtD
Imipramine—Aprindine—CALM1—Alzheimer's disease	0.00028	0.0656	CrCbGaD
Imipramine—Urethral disorder—Donepezil—Alzheimer's disease	0.000279	0.00221	CcSEcCtD
Imipramine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000278	0.0022	CcSEcCtD
Imipramine—Convulsion—Galantamine—Alzheimer's disease	0.000277	0.00219	CcSEcCtD
Imipramine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000276	0.00219	CcSEcCtD
Imipramine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000276	0.00219	CcSEcCtD
Imipramine—Hypertension—Galantamine—Alzheimer's disease	0.000276	0.00219	CcSEcCtD
Imipramine—Dimetacrine—ACHE—Alzheimer's disease	0.000275	0.0644	CrCbGaD
Imipramine—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000272	0.00216	CcSEcCtD
Imipramine—Anxiety—Galantamine—Alzheimer's disease	0.000271	0.00215	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00027	0.00214	CcSEcCtD
Imipramine—Discomfort—Galantamine—Alzheimer's disease	0.000269	0.00213	CcSEcCtD
Imipramine—Agranulocytosis—Memantine—Alzheimer's disease	0.000269	0.00213	CcSEcCtD
Imipramine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000266	0.00211	CcSEcCtD
Imipramine—Dry mouth—Galantamine—Alzheimer's disease	0.000266	0.00211	CcSEcCtD
Imipramine—Tinnitus—Donepezil—Alzheimer's disease	0.000265	0.0021	CcSEcCtD
Imipramine—Confusional state—Galantamine—Alzheimer's disease	0.000263	0.00208	CcSEcCtD
Imipramine—Hepatitis—Memantine—Alzheimer's disease	0.000258	0.00205	CcSEcCtD
Imipramine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000257	0.00204	CcSEcCtD
Imipramine—Hallucination—Memantine—Alzheimer's disease	0.000257	0.00204	CcSEcCtD
Imipramine—CHRM5—brain—Alzheimer's disease	0.000257	0.00406	CbGeAlD
Imipramine—Shock—Galantamine—Alzheimer's disease	0.000257	0.00203	CcSEcCtD
Imipramine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000256	0.00203	CcSEcCtD
Imipramine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000255	0.00202	CcSEcCtD
Imipramine—ABCB1—blood vessel—Alzheimer's disease	0.000255	0.00403	CbGeAlD
Imipramine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000255	0.00202	CcSEcCtD
Imipramine—Tachycardia—Galantamine—Alzheimer's disease	0.000255	0.00202	CcSEcCtD
Imipramine—Arrhythmia—Donepezil—Alzheimer's disease	0.000254	0.00201	CcSEcCtD
Imipramine—Skin disorder—Galantamine—Alzheimer's disease	0.000253	0.00201	CcSEcCtD
Imipramine—Urethral disorder—Memantine—Alzheimer's disease	0.000253	0.00201	CcSEcCtD
Imipramine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000253	0.002	CcSEcCtD
Imipramine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000252	0.002	CcSEcCtD
Imipramine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000252	0.00199	CcSEcCtD
Imipramine—Hallucination—Rivastigmine—Alzheimer's disease	0.000252	0.00199	CcSEcCtD
Imipramine—Alopecia—Donepezil—Alzheimer's disease	0.000251	0.00199	CcSEcCtD
Imipramine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00025	0.00198	CcSEcCtD
Imipramine—Mental disorder—Donepezil—Alzheimer's disease	0.000249	0.00198	CcSEcCtD
Imipramine—Anorexia—Galantamine—Alzheimer's disease	0.000249	0.00197	CcSEcCtD
Imipramine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000248	0.00196	CcSEcCtD
Imipramine—Malnutrition—Donepezil—Alzheimer's disease	0.000248	0.00196	CcSEcCtD
Imipramine—ORM1—nervous system—Alzheimer's disease	0.000247	0.00391	CbGeAlD
Imipramine—HRH1—forebrain—Alzheimer's disease	0.000246	0.00388	CbGeAlD
Imipramine—Tension—Donepezil—Alzheimer's disease	0.000243	0.00193	CcSEcCtD
Imipramine—Dysgeusia—Donepezil—Alzheimer's disease	0.000243	0.00192	CcSEcCtD
Imipramine—Eye disorder—Memantine—Alzheimer's disease	0.000241	0.00191	CcSEcCtD
Imipramine—Tinnitus—Memantine—Alzheimer's disease	0.000241	0.00191	CcSEcCtD
Imipramine—Nervousness—Donepezil—Alzheimer's disease	0.000241	0.00191	CcSEcCtD
Imipramine—Flushing—Memantine—Alzheimer's disease	0.00024	0.0019	CcSEcCtD
Imipramine—Cardiac disorder—Memantine—Alzheimer's disease	0.00024	0.0019	CcSEcCtD
Imipramine—ORM1—central nervous system—Alzheimer's disease	0.000238	0.00376	CbGeAlD
Imipramine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000236	0.00187	CcSEcCtD
Imipramine—Insomnia—Galantamine—Alzheimer's disease	0.000236	0.00187	CcSEcCtD
Imipramine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000236	0.00187	CcSEcCtD
Imipramine—ADRA1B—brain—Alzheimer's disease	0.000235	0.00371	CbGeAlD
Imipramine—Flushing—Rivastigmine—Alzheimer's disease	0.000235	0.00186	CcSEcCtD
Imipramine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000235	0.00186	CcSEcCtD
Imipramine—Angiopathy—Memantine—Alzheimer's disease	0.000234	0.00186	CcSEcCtD
Imipramine—Paraesthesia—Galantamine—Alzheimer's disease	0.000234	0.00186	CcSEcCtD
Imipramine—Vision blurred—Donepezil—Alzheimer's disease	0.000233	0.00185	CcSEcCtD
Imipramine—Immune system disorder—Memantine—Alzheimer's disease	0.000233	0.00185	CcSEcCtD
Imipramine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000233	0.00185	CcSEcCtD
Imipramine—HTR2A—embryo—Alzheimer's disease	0.000232	0.00367	CbGeAlD
Imipramine—Tremor—Donepezil—Alzheimer's disease	0.000232	0.00184	CcSEcCtD
Imipramine—Somnolence—Galantamine—Alzheimer's disease	0.000232	0.00184	CcSEcCtD
Imipramine—Arrhythmia—Memantine—Alzheimer's disease	0.000231	0.00183	CcSEcCtD
Imipramine—CHRM2—nervous system—Alzheimer's disease	0.000231	0.00364	CbGeAlD
Imipramine—SLC6A3—nervous system—Alzheimer's disease	0.00023	0.00363	CbGeAlD
Imipramine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00023	0.00182	CcSEcCtD
Imipramine—ADRA1D—brain—Alzheimer's disease	0.00023	0.00363	CbGeAlD
Imipramine—Dyspepsia—Galantamine—Alzheimer's disease	0.00023	0.00182	CcSEcCtD
Imipramine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000229	0.00182	CcSEcCtD
Imipramine—Alopecia—Memantine—Alzheimer's disease	0.000228	0.00181	CcSEcCtD
Imipramine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000228	0.00181	CcSEcCtD
Imipramine—Agitation—Donepezil—Alzheimer's disease	0.000228	0.0018	CcSEcCtD
Imipramine—Decreased appetite—Galantamine—Alzheimer's disease	0.000227	0.0018	CcSEcCtD
Imipramine—SLC22A1—nervous system—Alzheimer's disease	0.000227	0.00358	CbGeAlD
Imipramine—Mental disorder—Memantine—Alzheimer's disease	0.000226	0.00179	CcSEcCtD
Imipramine—HRH1—telencephalon—Alzheimer's disease	0.000226	0.00357	CbGeAlD
Imipramine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000226	0.00179	CcSEcCtD
Imipramine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000225	0.00178	CcSEcCtD
Imipramine—Malnutrition—Memantine—Alzheimer's disease	0.000225	0.00178	CcSEcCtD
Imipramine—Fatigue—Galantamine—Alzheimer's disease	0.000225	0.00178	CcSEcCtD
Imipramine—SLC22A4—cerebellum—Alzheimer's disease	0.000224	0.00354	CbGeAlD
Imipramine—Malaise—Donepezil—Alzheimer's disease	0.000223	0.00177	CcSEcCtD
Imipramine—Alopecia—Rivastigmine—Alzheimer's disease	0.000223	0.00177	CcSEcCtD
Imipramine—Constipation—Galantamine—Alzheimer's disease	0.000223	0.00177	CcSEcCtD
Imipramine—HTR2C—nervous system—Alzheimer's disease	0.000222	0.00351	CbGeAlD
Imipramine—CHRM2—central nervous system—Alzheimer's disease	0.000222	0.00351	CbGeAlD
Imipramine—Syncope—Donepezil—Alzheimer's disease	0.000222	0.00176	CcSEcCtD
Imipramine—SLC6A3—central nervous system—Alzheimer's disease	0.000222	0.0035	CbGeAlD
Imipramine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000221	0.00175	CcSEcCtD
Imipramine—Tension—Memantine—Alzheimer's disease	0.000221	0.00175	CcSEcCtD
Imipramine—Dysgeusia—Memantine—Alzheimer's disease	0.00022	0.00175	CcSEcCtD
Imipramine—Malnutrition—Rivastigmine—Alzheimer's disease	0.00022	0.00174	CcSEcCtD
Imipramine—Nervousness—Memantine—Alzheimer's disease	0.000218	0.00173	CcSEcCtD
Imipramine—SLC22A1—central nervous system—Alzheimer's disease	0.000218	0.00344	CbGeAlD
Imipramine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000218	0.00173	CcSEcCtD
Imipramine—CYP2E1—telencephalon—Alzheimer's disease	0.000217	0.00343	CbGeAlD
Imipramine—SLC22A3—nervous system—Alzheimer's disease	0.000217	0.00342	CbGeAlD
Imipramine—SLC6A3—cerebellum—Alzheimer's disease	0.000217	0.00342	CbGeAlD
Imipramine—Tension—Rivastigmine—Alzheimer's disease	0.000216	0.00171	CcSEcCtD
Imipramine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000215	0.00171	CcSEcCtD
Imipramine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000215	0.0017	CcSEcCtD
Imipramine—Convulsion—Donepezil—Alzheimer's disease	0.000215	0.0017	CcSEcCtD
Imipramine—HTR2C—central nervous system—Alzheimer's disease	0.000214	0.00338	CbGeAlD
Imipramine—Hypertension—Donepezil—Alzheimer's disease	0.000214	0.00169	CcSEcCtD
Imipramine—Nervousness—Rivastigmine—Alzheimer's disease	0.000214	0.00169	CcSEcCtD
Imipramine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000213	0.00169	CcSEcCtD
Imipramine—Vision blurred—Memantine—Alzheimer's disease	0.000212	0.00168	CcSEcCtD
Imipramine—SLC6A4—nervous system—Alzheimer's disease	0.000211	0.00333	CbGeAlD
Imipramine—Tremor—Memantine—Alzheimer's disease	0.000211	0.00167	CcSEcCtD
Imipramine—Anxiety—Donepezil—Alzheimer's disease	0.00021	0.00167	CcSEcCtD
Imipramine—CHRM1—nervous system—Alzheimer's disease	0.00021	0.00332	CbGeAlD
Imipramine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000209	0.00165	CcSEcCtD
Imipramine—SLC22A3—central nervous system—Alzheimer's disease	0.000209	0.00329	CbGeAlD
Imipramine—Discomfort—Donepezil—Alzheimer's disease	0.000208	0.00165	CcSEcCtD
Imipramine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000207	0.00164	CcSEcCtD
Imipramine—Agitation—Memantine—Alzheimer's disease	0.000207	0.00164	CcSEcCtD
Imipramine—Dry mouth—Donepezil—Alzheimer's disease	0.000206	0.00163	CcSEcCtD
Imipramine—Body temperature increased—Galantamine—Alzheimer's disease	0.000206	0.00163	CcSEcCtD
Imipramine—Abdominal pain—Galantamine—Alzheimer's disease	0.000206	0.00163	CcSEcCtD
Imipramine—Tremor—Rivastigmine—Alzheimer's disease	0.000206	0.00163	CcSEcCtD
Imipramine—HTR2A—forebrain—Alzheimer's disease	0.000206	0.00324	CbGeAlD
Imipramine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000204	0.00162	CcSEcCtD
Imipramine—Confusional state—Donepezil—Alzheimer's disease	0.000204	0.00162	CcSEcCtD
Imipramine—SLC6A4—central nervous system—Alzheimer's disease	0.000203	0.0032	CbGeAlD
Imipramine—Malaise—Memantine—Alzheimer's disease	0.000203	0.00161	CcSEcCtD
Imipramine—CHRM1—central nervous system—Alzheimer's disease	0.000202	0.00319	CbGeAlD
Imipramine—Agitation—Rivastigmine—Alzheimer's disease	0.000202	0.0016	CcSEcCtD
Imipramine—Oedema—Donepezil—Alzheimer's disease	0.000202	0.0016	CcSEcCtD
Imipramine—Syncope—Memantine—Alzheimer's disease	0.000202	0.0016	CcSEcCtD
Imipramine—Leukopenia—Memantine—Alzheimer's disease	0.000201	0.0016	CcSEcCtD
Imipramine—Infection—Donepezil—Alzheimer's disease	0.000201	0.00159	CcSEcCtD
Imipramine—Shock—Donepezil—Alzheimer's disease	0.000199	0.00158	CcSEcCtD
Imipramine—Palpitations—Memantine—Alzheimer's disease	0.000199	0.00158	CcSEcCtD
Imipramine—Malaise—Rivastigmine—Alzheimer's disease	0.000198	0.00157	CcSEcCtD
Imipramine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000198	0.00157	CcSEcCtD
Imipramine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000198	0.00157	CcSEcCtD
Imipramine—Loss of consciousness—Memantine—Alzheimer's disease	0.000198	0.00157	CcSEcCtD
Imipramine—Syncope—Rivastigmine—Alzheimer's disease	0.000197	0.00156	CcSEcCtD
Imipramine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000195	0.00155	CcSEcCtD
Imipramine—Convulsion—Memantine—Alzheimer's disease	0.000195	0.00154	CcSEcCtD
Imipramine—Palpitations—Rivastigmine—Alzheimer's disease	0.000194	0.00154	CcSEcCtD
Imipramine—Hypertension—Memantine—Alzheimer's disease	0.000194	0.00154	CcSEcCtD
Imipramine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000193	0.00153	CcSEcCtD
Imipramine—Anorexia—Donepezil—Alzheimer's disease	0.000193	0.00153	CcSEcCtD
Imipramine—Anxiety—Memantine—Alzheimer's disease	0.000191	0.00151	CcSEcCtD
Imipramine—Convulsion—Rivastigmine—Alzheimer's disease	0.000191	0.00151	CcSEcCtD
Imipramine—Hypertension—Rivastigmine—Alzheimer's disease	0.00019	0.00151	CcSEcCtD
Imipramine—Discomfort—Memantine—Alzheimer's disease	0.000189	0.0015	CcSEcCtD
Imipramine—HTR2A—telencephalon—Alzheimer's disease	0.000189	0.00298	CbGeAlD
Imipramine—CHRM3—nervous system—Alzheimer's disease	0.000188	0.00297	CbGeAlD
Imipramine—Dry mouth—Memantine—Alzheimer's disease	0.000187	0.00148	CcSEcCtD
Imipramine—CYP2D6—forebrain—Alzheimer's disease	0.000187	0.00296	CbGeAlD
Imipramine—HTR1A—nervous system—Alzheimer's disease	0.000187	0.00296	CbGeAlD
Imipramine—Asthenia—Galantamine—Alzheimer's disease	0.000187	0.00148	CcSEcCtD
Imipramine—Anxiety—Rivastigmine—Alzheimer's disease	0.000187	0.00148	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000186	0.00147	CcSEcCtD
Imipramine—SLC6A2—nervous system—Alzheimer's disease	0.000186	0.00293	CbGeAlD
Imipramine—Confusional state—Memantine—Alzheimer's disease	0.000185	0.00147	CcSEcCtD
Imipramine—Discomfort—Rivastigmine—Alzheimer's disease	0.000185	0.00147	CcSEcCtD
Imipramine—Oedema—Memantine—Alzheimer's disease	0.000184	0.00145	CcSEcCtD
Imipramine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000183	0.00145	CcSEcCtD
Imipramine—Insomnia—Donepezil—Alzheimer's disease	0.000183	0.00145	CcSEcCtD
Imipramine—Infection—Memantine—Alzheimer's disease	0.000182	0.00145	CcSEcCtD
Imipramine—SLC22A4—brain—Alzheimer's disease	0.000182	0.00287	CbGeAlD
Imipramine—Paraesthesia—Donepezil—Alzheimer's disease	0.000182	0.00144	CcSEcCtD
Imipramine—Confusional state—Rivastigmine—Alzheimer's disease	0.000181	0.00143	CcSEcCtD
Imipramine—CHRM3—central nervous system—Alzheimer's disease	0.000181	0.00286	CbGeAlD
Imipramine—Shock—Memantine—Alzheimer's disease	0.000181	0.00143	CcSEcCtD
Imipramine—HTR1A—central nervous system—Alzheimer's disease	0.00018	0.00285	CbGeAlD
Imipramine—Nervous system disorder—Memantine—Alzheimer's disease	0.00018	0.00143	CcSEcCtD
Imipramine—Somnolence—Donepezil—Alzheimer's disease	0.00018	0.00142	CcSEcCtD
Imipramine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00018	0.00142	CcSEcCtD
Imipramine—Oedema—Rivastigmine—Alzheimer's disease	0.00018	0.00142	CcSEcCtD
Imipramine—Tachycardia—Memantine—Alzheimer's disease	0.000179	0.00142	CcSEcCtD
Imipramine—HTR7—nervous system—Alzheimer's disease	0.000179	0.00282	CbGeAlD
Imipramine—SLC6A2—central nervous system—Alzheimer's disease	0.000179	0.00282	CbGeAlD
Imipramine—Diarrhoea—Galantamine—Alzheimer's disease	0.000178	0.00141	CcSEcCtD
Imipramine—Infection—Rivastigmine—Alzheimer's disease	0.000178	0.00141	CcSEcCtD
Imipramine—Skin disorder—Memantine—Alzheimer's disease	0.000178	0.00141	CcSEcCtD
Imipramine—Dyspepsia—Donepezil—Alzheimer's disease	0.000178	0.00141	CcSEcCtD
Imipramine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000177	0.00141	CcSEcCtD
Imipramine—Shock—Rivastigmine—Alzheimer's disease	0.000177	0.0014	CcSEcCtD
Imipramine—CHRM2—brain—Alzheimer's disease	0.000176	0.00278	CbGeAlD
Imipramine—HTR1A—cerebellum—Alzheimer's disease	0.000176	0.00278	CbGeAlD
Imipramine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000176	0.0014	CcSEcCtD
Imipramine—SLC6A3—brain—Alzheimer's disease	0.000176	0.00278	CbGeAlD
Imipramine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000176	0.00139	CcSEcCtD
Imipramine—Decreased appetite—Donepezil—Alzheimer's disease	0.000176	0.00139	CcSEcCtD
Imipramine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000175	0.00139	CcSEcCtD
Imipramine—Anorexia—Memantine—Alzheimer's disease	0.000175	0.00139	CcSEcCtD
Imipramine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000175	0.00138	CcSEcCtD
Imipramine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000174	0.00138	CcSEcCtD
Imipramine—Fatigue—Donepezil—Alzheimer's disease	0.000174	0.00138	CcSEcCtD
Imipramine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000174	0.00138	CcSEcCtD
Imipramine—SLC22A1—brain—Alzheimer's disease	0.000173	0.00273	CbGeAlD
Imipramine—Constipation—Donepezil—Alzheimer's disease	0.000173	0.00137	CcSEcCtD
Imipramine—ADRA1A—nervous system—Alzheimer's disease	0.000173	0.00272	CbGeAlD
Imipramine—Dizziness—Galantamine—Alzheimer's disease	0.000173	0.00137	CcSEcCtD
Imipramine—HTR7—central nervous system—Alzheimer's disease	0.000172	0.00272	CbGeAlD
Imipramine—CYP2D6—telencephalon—Alzheimer's disease	0.000172	0.00272	CbGeAlD
Imipramine—Anorexia—Rivastigmine—Alzheimer's disease	0.000171	0.00136	CcSEcCtD
Imipramine—HTR2C—brain—Alzheimer's disease	0.00017	0.00268	CbGeAlD
Imipramine—Amitriptyline—NTRK2—Alzheimer's disease	0.00017	0.0398	CrCbGaD
Imipramine—DRD2—nervous system—Alzheimer's disease	0.000169	0.00267	CbGeAlD
Imipramine—HTR7—cerebellum—Alzheimer's disease	0.000168	0.00266	CbGeAlD
Imipramine—KCNH2—nervous system—Alzheimer's disease	0.000167	0.00263	CbGeAlD
Imipramine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000167	0.00132	CcSEcCtD
Imipramine—ADRA1A—central nervous system—Alzheimer's disease	0.000166	0.00262	CbGeAlD
Imipramine—Insomnia—Memantine—Alzheimer's disease	0.000166	0.00132	CcSEcCtD
Imipramine—Vomiting—Galantamine—Alzheimer's disease	0.000166	0.00131	CcSEcCtD
Imipramine—SLC22A3—brain—Alzheimer's disease	0.000166	0.00261	CbGeAlD
Imipramine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000165	0.00131	CcSEcCtD
Imipramine—Paraesthesia—Memantine—Alzheimer's disease	0.000165	0.00131	CcSEcCtD
Imipramine—Rash—Galantamine—Alzheimer's disease	0.000164	0.0013	CcSEcCtD
Imipramine—Dermatitis—Galantamine—Alzheimer's disease	0.000164	0.0013	CcSEcCtD
Imipramine—Headache—Galantamine—Alzheimer's disease	0.000163	0.0013	CcSEcCtD
Imipramine—Somnolence—Memantine—Alzheimer's disease	0.000163	0.00129	CcSEcCtD
Imipramine—DRD2—central nervous system—Alzheimer's disease	0.000163	0.00257	CbGeAlD
Imipramine—Insomnia—Rivastigmine—Alzheimer's disease	0.000162	0.00129	CcSEcCtD
Imipramine—ADRA1A—cerebellum—Alzheimer's disease	0.000162	0.00256	CbGeAlD
Imipramine—Dyspepsia—Memantine—Alzheimer's disease	0.000162	0.00128	CcSEcCtD
Imipramine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000161	0.00128	CcSEcCtD
Imipramine—SLC6A4—brain—Alzheimer's disease	0.000161	0.00254	CbGeAlD
Imipramine—Urticaria—Donepezil—Alzheimer's disease	0.000161	0.00127	CcSEcCtD
Imipramine—CHRM1—brain—Alzheimer's disease	0.000161	0.00253	CbGeAlD
Imipramine—KCNH2—central nervous system—Alzheimer's disease	0.00016	0.00253	CbGeAlD
Imipramine—Body temperature increased—Donepezil—Alzheimer's disease	0.00016	0.00127	CcSEcCtD
Imipramine—Abdominal pain—Donepezil—Alzheimer's disease	0.00016	0.00127	CcSEcCtD
Imipramine—Somnolence—Rivastigmine—Alzheimer's disease	0.00016	0.00127	CcSEcCtD
Imipramine—Decreased appetite—Memantine—Alzheimer's disease	0.00016	0.00126	CcSEcCtD
Imipramine—DRD2—cerebellum—Alzheimer's disease	0.000159	0.00251	CbGeAlD
Imipramine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000158	0.00126	CcSEcCtD
Imipramine—Fatigue—Memantine—Alzheimer's disease	0.000158	0.00125	CcSEcCtD
Imipramine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000158	0.00125	CcSEcCtD
Imipramine—Constipation—Memantine—Alzheimer's disease	0.000157	0.00124	CcSEcCtD
Imipramine—KCNH2—cerebellum—Alzheimer's disease	0.000157	0.00248	CbGeAlD
Imipramine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000156	0.00124	CcSEcCtD
Imipramine—Benazepril—MTHFR—Alzheimer's disease	0.000156	0.0365	CrCbGaD
Imipramine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000155	0.00123	CcSEcCtD
Imipramine—Nausea—Galantamine—Alzheimer's disease	0.000155	0.00123	CcSEcCtD
Imipramine—Fatigue—Rivastigmine—Alzheimer's disease	0.000155	0.00123	CcSEcCtD
Imipramine—Constipation—Rivastigmine—Alzheimer's disease	0.000154	0.00122	CcSEcCtD
Imipramine—ABCB1—embryo—Alzheimer's disease	0.000152	0.0024	CbGeAlD
Imipramine—Feeling abnormal—Memantine—Alzheimer's disease	0.000151	0.0012	CcSEcCtD
Imipramine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00015	0.00119	CcSEcCtD
Imipramine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000148	0.00117	CcSEcCtD
Imipramine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000147	0.00116	CcSEcCtD
Imipramine—Urticaria—Memantine—Alzheimer's disease	0.000146	0.00116	CcSEcCtD
Imipramine—Abdominal pain—Memantine—Alzheimer's disease	0.000145	0.00115	CcSEcCtD
Imipramine—Body temperature increased—Memantine—Alzheimer's disease	0.000145	0.00115	CcSEcCtD
Imipramine—Asthenia—Donepezil—Alzheimer's disease	0.000145	0.00115	CcSEcCtD
Imipramine—CHRM3—brain—Alzheimer's disease	0.000144	0.00227	CbGeAlD
Imipramine—HTR1A—brain—Alzheimer's disease	0.000143	0.00226	CbGeAlD
Imipramine—Pruritus—Donepezil—Alzheimer's disease	0.000143	0.00113	CcSEcCtD
Imipramine—Urticaria—Rivastigmine—Alzheimer's disease	0.000143	0.00113	CcSEcCtD
Imipramine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000142	0.00112	CcSEcCtD
Imipramine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000142	0.00112	CcSEcCtD
Imipramine—SLC6A2—brain—Alzheimer's disease	0.000142	0.00224	CbGeAlD
Imipramine—Diarrhoea—Donepezil—Alzheimer's disease	0.000138	0.0011	CcSEcCtD
Imipramine—CYP2B6—nervous system—Alzheimer's disease	0.000137	0.00216	CbGeAlD
Imipramine—HTR7—brain—Alzheimer's disease	0.000137	0.00216	CbGeAlD
Imipramine—ABCB1—forebrain—Alzheimer's disease	0.000135	0.00213	CbGeAlD
Imipramine—Dizziness—Donepezil—Alzheimer's disease	0.000134	0.00106	CcSEcCtD
Imipramine—HRH1—nervous system—Alzheimer's disease	0.000134	0.00211	CbGeAlD
Imipramine—ADRA1A—brain—Alzheimer's disease	0.000132	0.00208	CbGeAlD
Imipramine—CYP2B6—central nervous system—Alzheimer's disease	0.000132	0.00208	CbGeAlD
Imipramine—Asthenia—Memantine—Alzheimer's disease	0.000132	0.00104	CcSEcCtD
Imipramine—Pruritus—Memantine—Alzheimer's disease	0.00013	0.00103	CcSEcCtD
Imipramine—DRD2—brain—Alzheimer's disease	0.000129	0.00204	CbGeAlD
Imipramine—Asthenia—Rivastigmine—Alzheimer's disease	0.000129	0.00102	CcSEcCtD
Imipramine—HRH1—central nervous system—Alzheimer's disease	0.000129	0.00203	CbGeAlD
Imipramine—Vomiting—Donepezil—Alzheimer's disease	0.000129	0.00102	CcSEcCtD
Imipramine—CYP2E1—nervous system—Alzheimer's disease	0.000128	0.00203	CbGeAlD
Imipramine—Rash—Donepezil—Alzheimer's disease	0.000127	0.00101	CcSEcCtD
Imipramine—KCNH2—brain—Alzheimer's disease	0.000127	0.00201	CbGeAlD
Imipramine—Dermatitis—Donepezil—Alzheimer's disease	0.000127	0.00101	CcSEcCtD
Imipramine—Pruritus—Rivastigmine—Alzheimer's disease	0.000127	0.00101	CcSEcCtD
Imipramine—Benazepril—ACE—Alzheimer's disease	0.000127	0.0297	CrCbGaD
Imipramine—Headache—Donepezil—Alzheimer's disease	0.000127	0.001	CcSEcCtD
Imipramine—Diarrhoea—Memantine—Alzheimer's disease	0.000126	0.000995	CcSEcCtD
Imipramine—ABCB1—telencephalon—Alzheimer's disease	0.000124	0.00195	CbGeAlD
Imipramine—CYP2E1—central nervous system—Alzheimer's disease	0.000124	0.00195	CbGeAlD
Imipramine—Mianserin—HTR6—Alzheimer's disease	0.000123	0.0289	CrCbGaD
Imipramine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000123	0.000974	CcSEcCtD
Imipramine—Dizziness—Memantine—Alzheimer's disease	0.000121	0.000962	CcSEcCtD
Imipramine—CYP2E1—cerebellum—Alzheimer's disease	0.000121	0.00191	CbGeAlD
Imipramine—Nausea—Donepezil—Alzheimer's disease	0.00012	0.000952	CcSEcCtD
Imipramine—Dizziness—Rivastigmine—Alzheimer's disease	0.000119	0.000941	CcSEcCtD
Imipramine—Vomiting—Memantine—Alzheimer's disease	0.000117	0.000925	CcSEcCtD
Imipramine—Rash—Memantine—Alzheimer's disease	0.000116	0.000917	CcSEcCtD
Imipramine—Dermatitis—Memantine—Alzheimer's disease	0.000116	0.000916	CcSEcCtD
Imipramine—Headache—Memantine—Alzheimer's disease	0.000115	0.000911	CcSEcCtD
Imipramine—Vomiting—Rivastigmine—Alzheimer's disease	0.000114	0.000905	CcSEcCtD
Imipramine—Rash—Rivastigmine—Alzheimer's disease	0.000113	0.000897	CcSEcCtD
Imipramine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000113	0.000896	CcSEcCtD
Imipramine—Clomipramine—HTR6—Alzheimer's disease	0.000113	0.0264	CrCbGaD
Imipramine—Headache—Rivastigmine—Alzheimer's disease	0.000113	0.000891	CcSEcCtD
Imipramine—HTR2A—nervous system—Alzheimer's disease	0.000112	0.00176	CbGeAlD
Imipramine—Promethazine—CALM1—Alzheimer's disease	0.000111	0.026	CrCbGaD
Imipramine—Nortriptyline—HTR6—Alzheimer's disease	0.00011	0.0258	CrCbGaD
Imipramine—Nausea—Memantine—Alzheimer's disease	0.000109	0.000864	CcSEcCtD
Imipramine—HTR2A—central nervous system—Alzheimer's disease	0.000107	0.0017	CbGeAlD
Imipramine—Nausea—Rivastigmine—Alzheimer's disease	0.000107	0.000845	CcSEcCtD
Imipramine—HTR2A—cerebellum—Alzheimer's disease	0.000105	0.00166	CbGeAlD
Imipramine—CYP2B6—brain—Alzheimer's disease	0.000105	0.00165	CbGeAlD
Imipramine—CYP3A4—nervous system—Alzheimer's disease	0.000103	0.00163	CbGeAlD
Imipramine—HRH1—brain—Alzheimer's disease	0.000102	0.00161	CbGeAlD
Imipramine—CYP2D6—nervous system—Alzheimer's disease	0.000102	0.0016	CbGeAlD
Imipramine—CYP3A4—central nervous system—Alzheimer's disease	9.95e-05	0.00157	CbGeAlD
Imipramine—Doxepin—HTR6—Alzheimer's disease	9.88e-05	0.0232	CrCbGaD
Imipramine—CYP2E1—brain—Alzheimer's disease	9.81e-05	0.00155	CbGeAlD
Imipramine—CYP2D6—central nervous system—Alzheimer's disease	9.79e-05	0.00154	CbGeAlD
Imipramine—Ethopropazine—BCHE—Alzheimer's disease	9.59e-05	0.0225	CrCbGaD
Imipramine—CYP2D6—cerebellum—Alzheimer's disease	9.57e-05	0.00151	CbGeAlD
Imipramine—Chlorpromazine—CALM1—Alzheimer's disease	8.57e-05	0.0201	CrCbGaD
Imipramine—HTR2A—brain—Alzheimer's disease	8.53e-05	0.00135	CbGeAlD
Imipramine—Triflupromazine—BCHE—Alzheimer's disease	7.86e-05	0.0184	CrCbGaD
Imipramine—CYP2D6—brain—Alzheimer's disease	7.77e-05	0.00123	CbGeAlD
Imipramine—Chlorpromazine—HTR6—Alzheimer's disease	7.73e-05	0.0181	CrCbGaD
Imipramine—Amitriptyline—HTR6—Alzheimer's disease	7.64e-05	0.0179	CrCbGaD
Imipramine—ABCB1—nervous system—Alzheimer's disease	7.31e-05	0.00115	CbGeAlD
Imipramine—ABCB1—central nervous system—Alzheimer's disease	7.04e-05	0.00111	CbGeAlD
Imipramine—Tripelennamine—CYP2D6—Alzheimer's disease	6.94e-05	0.0163	CrCbGaD
Imipramine—ABCB1—cerebellum—Alzheimer's disease	6.88e-05	0.00109	CbGeAlD
Imipramine—Cyamemazine—HTR2A—Alzheimer's disease	6.79e-05	0.0159	CrCbGaD
Imipramine—Aprindine—CYP2D6—Alzheimer's disease	6.79e-05	0.0159	CrCbGaD
Imipramine—Cyclobenzaprine—HTR2A—Alzheimer's disease	6.31e-05	0.0148	CrCbGaD
Imipramine—Epinastine—HTR2A—Alzheimer's disease	6.27e-05	0.0147	CrCbGaD
Imipramine—Cyclobenzaprine—CYP2D6—Alzheimer's disease	5.77e-05	0.0135	CrCbGaD
Imipramine—Epinastine—CYP2D6—Alzheimer's disease	5.73e-05	0.0134	CrCbGaD
Imipramine—ABCB1—brain—Alzheimer's disease	5.59e-05	0.000882	CbGeAlD
Imipramine—Maprotiline—HTR2A—Alzheimer's disease	5.39e-05	0.0126	CrCbGaD
Imipramine—Mequitazine—CYP2D6—Alzheimer's disease	5.39e-05	0.0126	CrCbGaD
Imipramine—Maprotiline—CYP2D6—Alzheimer's disease	4.93e-05	0.0116	CrCbGaD
Imipramine—Mianserin—SLC6A4—Alzheimer's disease	4.72e-05	0.0111	CrCbGaD
Imipramine—Acepromazine—HTR2A—Alzheimer's disease	4.36e-05	0.0102	CrCbGaD
Imipramine—Nortriptyline—PTGS1—Alzheimer's disease	4.35e-05	0.0102	CrCbGaD
Imipramine—Clomipramine—SLC6A4—Alzheimer's disease	4.31e-05	0.0101	CrCbGaD
Imipramine—Thioproperazine—HTR2A—Alzheimer's disease	4.26e-05	0.01	CrCbGaD
Imipramine—Nortriptyline—SLC6A4—Alzheimer's disease	4.22e-05	0.00989	CrCbGaD
Imipramine—Pipotiazine—HTR2A—Alzheimer's disease	4.19e-05	0.00984	CrCbGaD
Imipramine—Diphenhydramine—PTGS1—Alzheimer's disease	4.02e-05	0.00944	CrCbGaD
Imipramine—Trimipramine—SLC6A4—Alzheimer's disease	3.97e-05	0.00931	CrCbGaD
Imipramine—Pipotiazine—CYP2D6—Alzheimer's disease	3.84e-05	0.00899	CrCbGaD
Imipramine—Chlorpromazine—BCHE—Alzheimer's disease	3.79e-05	0.00889	CrCbGaD
Imipramine—Doxepin—SLC6A4—Alzheimer's disease	3.78e-05	0.00887	CrCbGaD
Imipramine—Prochlorperazine—CYP2D6—Alzheimer's disease	3.67e-05	0.0086	CrCbGaD
Imipramine—Mianserin—HTR2A—Alzheimer's disease	3.62e-05	0.0085	CrCbGaD
Imipramine—Desipramine—SLC6A4—Alzheimer's disease	3.47e-05	0.00814	CrCbGaD
Imipramine—Clomipramine—HTR2A—Alzheimer's disease	3.32e-05	0.00777	CrCbGaD
Imipramine—Mianserin—CYP2D6—Alzheimer's disease	3.31e-05	0.00777	CrCbGaD
Imipramine—Nortriptyline—HTR2A—Alzheimer's disease	3.24e-05	0.0076	CrCbGaD
Imipramine—Trimipramine—HTR2A—Alzheimer's disease	3.05e-05	0.00715	CrCbGaD
Imipramine—Clomipramine—CYP2D6—Alzheimer's disease	3.03e-05	0.00711	CrCbGaD
Imipramine—Methotrimeprazine—HTR2A—Alzheimer's disease	2.98e-05	0.00699	CrCbGaD
Imipramine—Nortriptyline—CYP2D6—Alzheimer's disease	2.96e-05	0.00695	CrCbGaD
Imipramine—Promethazine—HTR2A—Alzheimer's disease	2.94e-05	0.00689	CrCbGaD
Imipramine—Amitriptyline—SLC6A4—Alzheimer's disease	2.93e-05	0.00686	CrCbGaD
Imipramine—Doxepin—HTR2A—Alzheimer's disease	2.91e-05	0.00682	CrCbGaD
Imipramine—Trimipramine—CYP2D6—Alzheimer's disease	2.79e-05	0.00654	CrCbGaD
Imipramine—Diphenhydramine—CYP2D6—Alzheimer's disease	2.74e-05	0.00642	CrCbGaD
Imipramine—Methotrimeprazine—CYP2D6—Alzheimer's disease	2.73e-05	0.00639	CrCbGaD
Imipramine—Promethazine—CYP2D6—Alzheimer's disease	2.69e-05	0.0063	CrCbGaD
Imipramine—Desipramine—HTR2A—Alzheimer's disease	2.67e-05	0.00626	CrCbGaD
Imipramine—Doxepin—CYP2D6—Alzheimer's disease	2.66e-05	0.00623	CrCbGaD
Imipramine—Promazine—HTR2A—Alzheimer's disease	2.58e-05	0.00606	CrCbGaD
Imipramine—Desipramine—CYP2D6—Alzheimer's disease	2.44e-05	0.00572	CrCbGaD
Imipramine—Chlorpromazine—HTR2A—Alzheimer's disease	2.27e-05	0.00533	CrCbGaD
Imipramine—Amitriptyline—HTR2A—Alzheimer's disease	2.25e-05	0.00527	CrCbGaD
Imipramine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.08e-05	0.00488	CrCbGaD
Imipramine—Amitriptyline—CYP2D6—Alzheimer's disease	2.06e-05	0.00482	CrCbGaD
Imipramine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	1.98e-06	2.52e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—INS—Alzheimer's disease	1.98e-06	2.51e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	1.98e-06	2.51e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.97e-06	2.5e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	1.97e-06	2.5e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	1.97e-06	2.5e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	1.97e-06	2.49e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.96e-06	2.49e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	1.96e-06	2.49e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	1.96e-06	2.48e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	1.96e-06	2.48e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	1.95e-06	2.48e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	1.95e-06	2.47e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	1.95e-06	2.47e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	1.95e-06	2.47e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—INS—Alzheimer's disease	1.95e-06	2.47e-05	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	1.94e-06	2.47e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—INS—Alzheimer's disease	1.94e-06	2.47e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	1.94e-06	2.46e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	1.94e-06	2.46e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	1.94e-06	2.46e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.93e-06	2.45e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	1.93e-06	2.45e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.93e-06	2.45e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	1.93e-06	2.44e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	1.92e-06	2.44e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	1.92e-06	2.44e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	1.92e-06	2.44e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.92e-06	2.43e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	1.92e-06	2.43e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	1.91e-06	2.43e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	1.91e-06	2.43e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	1.91e-06	2.43e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	1.91e-06	2.43e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.91e-06	2.42e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.91e-06	2.42e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	1.9e-06	2.41e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.89e-06	2.4e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.89e-06	2.4e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	1.89e-06	2.39e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	1.88e-06	2.39e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	1.88e-06	2.39e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	1.88e-06	2.39e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	1.88e-06	2.39e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	1.88e-06	2.38e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	1.88e-06	2.38e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.88e-06	2.38e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.87e-06	2.38e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	1.87e-06	2.37e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.85e-06	2.35e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	1.85e-06	2.35e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.85e-06	2.35e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-06	2.34e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.84e-06	2.34e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	1.81e-06	2.3e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.79e-06	2.28e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.79e-06	2.27e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.77e-06	2.25e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.77e-06	2.24e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.76e-06	2.24e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.76e-06	2.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.76e-06	2.24e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.76e-06	2.23e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.76e-06	2.23e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.74e-06	2.21e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.74e-06	2.21e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.74e-06	2.21e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.74e-06	2.2e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.74e-06	2.2e-05	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AKT1—Alzheimer's disease	1.72e-06	2.19e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.72e-06	2.18e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—Alzheimer's disease	1.71e-06	2.18e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.71e-06	2.17e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.71e-06	2.16e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.7e-06	2.16e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.7e-06	2.16e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.7e-06	2.16e-05	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.69e-06	2.15e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.69e-06	2.15e-05	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.68e-06	2.14e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.68e-06	2.13e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.68e-06	2.13e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.67e-06	2.12e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.67e-06	2.12e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.67e-06	2.12e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.67e-06	2.11e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.66e-06	2.1e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.66e-06	2.1e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.63e-06	2.07e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.63e-06	2.07e-05	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AKT1—Alzheimer's disease	1.63e-06	2.07e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.62e-06	2.06e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.62e-06	2.05e-05	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.61e-06	2.05e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.61e-06	2.04e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.6e-06	2.03e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.6e-06	2.03e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.6e-06	2.02e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.59e-06	2.02e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.59e-06	2.01e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.56e-06	1.98e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.54e-06	1.96e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.54e-06	1.95e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.53e-06	1.95e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.53e-06	1.94e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.53e-06	1.94e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.5e-06	1.9e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.5e-06	1.9e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.49e-06	1.9e-05	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.49e-06	1.89e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.47e-06	1.87e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.47e-06	1.87e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.47e-06	1.86e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—INS—Alzheimer's disease	1.46e-06	1.86e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	1.86e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.46e-06	1.86e-05	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.46e-06	1.86e-05	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.46e-06	1.85e-05	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.46e-06	1.85e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.45e-06	1.84e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.45e-06	1.84e-05	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.45e-06	1.84e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-06	1.84e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-06	1.84e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-06	1.83e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.44e-06	1.83e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.44e-06	1.82e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.44e-06	1.82e-05	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.44e-06	1.82e-05	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.43e-06	1.82e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-06	1.82e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.43e-06	1.81e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.42e-06	1.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.42e-06	1.81e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.42e-06	1.8e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.42e-06	1.8e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-06	1.79e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-06	1.79e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.41e-06	1.79e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.38e-06	1.76e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—INS—Alzheimer's disease	1.38e-06	1.75e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.38e-06	1.75e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.37e-06	1.74e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.37e-06	1.74e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.37e-06	1.74e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.36e-06	1.72e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.36e-06	1.72e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.35e-06	1.72e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.35e-06	1.71e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.33e-06	1.68e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.33e-06	1.68e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-06	1.68e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.32e-06	1.68e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.32e-06	1.67e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.32e-06	1.67e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.31e-06	1.67e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.31e-06	1.66e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.31e-06	1.66e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	1.66e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	1.66e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	1.65e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.3e-06	1.65e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.28e-06	1.63e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.26e-06	1.6e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.26e-06	1.59e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.25e-06	1.59e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	1.58e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.23e-06	1.57e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-06	1.56e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-06	1.56e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.23e-06	1.56e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.23e-06	1.56e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	1.55e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.22e-06	1.55e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.21e-06	1.54e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.21e-06	1.53e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	1.53e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.2e-06	1.53e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.2e-06	1.53e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.19e-06	1.51e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.18e-06	1.49e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—INS—Alzheimer's disease	1.17e-06	1.48e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.16e-06	1.47e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.15e-06	1.46e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.13e-06	1.44e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	1.13e-06	1.43e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	1.43e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	1.43e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.43e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	1.12e-06	1.42e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	1.11e-06	1.41e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	1.11e-06	1.41e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.11e-06	1.41e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.11e-06	1.4e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.08e-06	1.37e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.08e-06	1.37e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.08e-06	1.37e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.07e-06	1.36e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.06e-06	1.35e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.06e-06	1.34e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.05e-06	1.33e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-06	1.32e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.03e-06	1.3e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	1.3e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AKT1—Alzheimer's disease	1.01e-06	1.28e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	9.85e-07	1.25e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	9.8e-07	1.24e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	9.45e-07	1.2e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.38e-07	1.19e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	9.38e-07	1.19e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AKT1—Alzheimer's disease	9.31e-07	1.18e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	9.3e-07	1.18e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	9.28e-07	1.18e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	9.25e-07	1.17e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	9.22e-07	1.17e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	9.2e-07	1.17e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	9.13e-07	1.16e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	9.1e-07	1.15e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.09e-07	1.15e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	9.04e-07	1.15e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—INS—Alzheimer's disease	9.03e-07	1.15e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	8.65e-07	1.1e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	8.65e-07	1.1e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	8.51e-07	1.08e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	8.49e-07	1.08e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	8.46e-07	1.07e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	8.44e-07	1.07e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	8.35e-07	1.06e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	8.33e-07	1.06e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	8.01e-07	1.02e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	7.98e-07	1.01e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.92e-07	1e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	7.85e-07	9.96e-06	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	7.84e-07	9.95e-06	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	7.83e-07	9.94e-06	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	7.81e-07	9.91e-06	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	7.78e-07	9.88e-06	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	7.71e-07	9.78e-06	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.69e-07	9.75e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.24e-07	9.19e-06	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	6.05e-07	7.68e-06	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.91e-07	7.49e-06	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.56e-07	7.06e-06	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.71e-07	5.98e-06	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.64e-07	4.62e-06	CbGpPWpGaD
